Literature DB >> 18784816

Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress.

Jinglan Zhang1, Junwei Yang, Youhua Liu.   

Abstract

Hepatocyte growth factor (HGF) is known to promote renal epithelial cell survival by dual mechanisms involving Bad phosphorylation and Bcl-xL induction. However, it remains elusive as to the relative contributions of these two events to HGF-mediated cytoprotection. Here we investigated the role and mechanism of HGF in protecting renal epithelial cells from death induced by oxidant stress both in vitro and in vivo. Simultaneous incubation of human kidney proximal tubular epithelial cells (HKC-8) with HGF failed to protect them from oxidant stress-induced cell death, even though it was capable of inducing endogenous Akt and Bad phosphorylation. However, pre-incubation of HKC-8 cells with HGF for 48 hours dramatically promoted their survival and prevented caspase-3 cleavage and activation induced by H(2)O(2). A close association between Bcl-xL induction and effective cytoprotection by HGF was observed in HKC-8 cells after H(2)O(2) treatment. Furthermore, ectopic expression of exogenous Bcl-xL via adenoviral vector prevented H(2)O(2)-triggered caspase-3 activation. In a mouse model of acute kidney injury induced by ischemia/reperfusion, pre-administration of HGF expression vector drastically prevented apoptosis and largely preserved kidney function, whereas much less protective effect was observed when HGF gene was given immediately after ischemic injury. These results suggest that Bcl-xL induction plays an imperative role in mediating HGF cytoprotection of renal epithelial cells after death challenge.

Entities:  

Keywords:  Bad; Bcl-xL; HGF; acute kidney injury; apoptosis; c-met; ischemia/reperfusion

Year:  2008        PMID: 18784816      PMCID: PMC2480566     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  35 in total

Review 1.  The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing.

Authors:  Kevin Conway; Patricia Price; Keith G Harding; Wen G Jiang
Journal:  Wound Repair Regen       Date:  2006 Jan-Feb       Impact factor: 3.617

2.  Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.

Authors:  Zhaodong Li; Shinya Mizuno; Toshikazu Nakamura
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-26       Impact factor: 4.052

3.  Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells.

Authors:  Xiaoyan Wen; Yingjian Li; Kebin Hu; Chunsun Dai; Youhua Liu
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

4.  Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.

Authors:  A Fornoni; H Li; A Foschi; G E Striker; L J Striker
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

5.  Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure.

Authors:  M Franquesa; G Alperovich; I Herrero-Fresneda; N Lloberas; N Bolaños; C Fillat; I Rama; J M Cruzado; J M Grinyó; J Torras
Journal:  Gene Ther       Date:  2005-11       Impact factor: 5.250

6.  Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis.

Authors:  Michela Fassetta; Lorenza D'Alessandro; Nadia Coltella; Maria Flavia Di Renzo; Andrea Rasola
Journal:  Cell Signal       Date:  2006-05-03       Impact factor: 4.315

7.  Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms.

Authors:  Y Liu
Journal:  Am J Physiol       Date:  1999-10

8.  Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice.

Authors:  Qingqing Wei; Xiao-Ming Yin; Mong-Heng Wang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2005-08-16

Review 9.  c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.

Authors:  Martin Sattler; Ravi Salgia
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

10.  Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.

Authors:  Ruoyun Tan; Xianghong Zhang; Junwei Yang; Yingjian Li; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2007-07-11       Impact factor: 10.121

View more
  14 in total

1.  Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.

Authors:  Chunsun Dai; Moin A Saleem; Lawrence B Holzman; Peter Mathieson; Youhua Liu
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

Review 2.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

3.  Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.

Authors:  Cleide G da Silva; Elizabeth R Maccariello; Szuhuei Wu Wilson; Prabhakar Putheti; Soizic Daniel; Scott M Damrauer; Clayton R Peterson; Jeffrey J Siracuse; Elzbieta Kaczmarek; Christiane Ferran
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

4.  HGF/MET signaling promotes glioma growth via up-regulation of Cox-2 expression and PGE2 production.

Authors:  Yan Zhao; Ying Sun; Haiyan Zhang; Xing Liu; Wenzong Du; Yongli Li; Junhe Zhang; Lingchao Chen; Chuanlu Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

5.  EGFR activity is required for renal tubular cell dedifferentiation and proliferation in a murine model of folic acid-induced acute kidney injury.

Authors:  Song He; Na Liu; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-19

6.  Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway.

Authors:  Zhihui Lu; Nana Song; Bo Shen; XiaLian Xu; Yi Fang; Yiqin Shi; Yichun Ning; Jiachang Hu; Yan Dai; Xiaoqiang Ding; Jianzhou Zou; Jie Teng
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

7.  Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors.

Authors:  Xiaobo Cao; James Littlejohn; Charles Rodarte; Lidong Zhang; Benjamin Martino; Philip Rascoe; Kamran Hamid; Daniel Jupiter; W Roy Smythe
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

8.  Hepatocyte growth factor inhibits apoptosis by the profibrotic factor angiotensin II via extracellular signal-regulated kinase 1/2 in endothelial cells and tissue explants.

Authors:  Young H Lee; Ana P Marquez; Ognoon Mungunsukh; Regina M Day
Journal:  Mol Biol Cell       Date:  2010-10-06       Impact factor: 4.138

9.  Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis.

Authors:  Ferenc Sipos; Miklós Constantinovits; Gábor Valcz; Zsolt Tulassay; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

10.  Late intervention with the small molecule BB3 mitigates postischemic kidney injury.

Authors:  Prakash Narayan; Bin Duan; Kai Jiang; Jingsong Li; Latha Paka; Michael A Yamin; Scott L Friedman; Matthew R Weir; Itzhak D Goldberg
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.